Apr 17 2024 |
China’s Securities Regulatory Commission Proposes Increasing Patent Requirement for IPOs |
Schwegman, Lundberg & Woessner, P.A. |
Apr 15 2024 |
France’s Arkema S.A. Sues Shanghai Huayi Group Co., Ltd. for 430 Million RMB Patent Infringement |
Schwegman, Lundberg & Woessner, P.A. |
Apr 12 2024 |
China’s National Intellectual Property Administration Joins the Patent Prosecution Highway Improvement Initiative in Cooperation with the IP5 |
Schwegman, Lundberg & Woessner, P.A. |
Apr 12 2024 |
The BR International Trade Report: April 2024 |
Blank Rome LLP |
Apr 11 2024 |
China’s National Intellectual Property Administration Issues Annual Work Guidelines for Promoting High-Quality Development of IP Rights (2024) |
Schwegman, Lundberg & Woessner, P.A. |
Apr 11 2024 |
China Issues Regulations on Facilitating and Regulating Cross-Border Data Flow |
Sheppard, Mullin, Richter & Hampton LLP |
Apr 11 2024 |
China Semiconductor Export Regulations, Episode V – Updates and Corrections to the Advanced Computing and Semiconductor Regulations |
Sheppard, Mullin, Richter & Hampton LLP |
Apr 10 2024 |
3.5-Year Prison Sentence for Counterfeiting Maotai, the National Drink of China |
Schwegman, Lundberg & Woessner, P.A. |
Apr 9 2024 |
Safe Harbors Part I – from Regulating to Facilitating: Key Developments in China's Safe Harbor Rules |
K&L Gates LLP |
Apr 8 2024 |
Competition Currents | April 2024 |
Greenberg Traurig, LLP |
Apr 5 2024 |
China (Partially) Switches to Common Law System? |
Schwegman, Lundberg & Woessner, P.A. |
Mar 31 2024 |
Highlights of Revised Regulations for Implementing Patent Law of China |
Sheppard, Mullin, Richter & Hampton LLP |
Mar 29 2024 |
China Finalizes New Regulations to Relax Personal Data Exports from China |
Squire Patton Boggs (US) LLP |
Mar 29 2024 |
China Relaxes Requirements for Cross-Border Data Transfers |
Greenberg Traurig, LLP |
Mar 28 2024 |
New Era of Regulation for Cross-Border Transfers in China |
Hunton Andrews Kurth |
Mar 27 2024 |
China’s National Intellectual Property Administration Releases 2024 Budget |
Schwegman, Lundberg & Woessner, P.A. |
Mar 26 2024 |
China Newsletter | Q4 2023/Issue No. 59 |
Greenberg Traurig, LLP |
Mar 24 2024 |
April 2024 Visa Bulletin Updates for the EB-5 Category |
Greenberg Traurig, LLP |
Mar 19 2024 |
The BR International Trade Newsletter: February 2024 |
Blank Rome LLP |
Mar 19 2024 |
Navigating Global Trade Regulations: Minimizing Supply Chain Risks When Importing from Abroad |
Foley & Lardner LLP |
Mar 19 2024 |
Cross Border Catch-Up: Digital Nomad Visa Trend in East Asia [Podcast] |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
Mar 18 2024 |
China Announces the Standard for Food Packaging Adhesives |
Keller and Heckman LLP |
Mar 15 2024 |
New Antidumping and Countervailing Petitions on 2,4-Dichlorophenoxyacetic Acid from China and India |
ArentFox Schiff LLP |
Mar 15 2024 |
China Announces the Standard for Food-Contact Adhesives |
Keller and Heckman LLP |
Mar 15 2024 |
The BR International Trade Newsletter: March 2024 |
Blank Rome LLP |
Mar 14 2024 |
China | Visa-Free Entry Scheme Further Expanded |
Berry Appleman & Leiden |
Mar 14 2024 |
April 2024 Visa Bulletin Updates |
Greenberg Traurig, LLP |
Mar 14 2024 |
Privacy Tip #391 – Potential Ban on TikTok in US Follows Ban in Other Countries |
Robinson & Cole LLP |
Mar 12 2024 |
April 2024 Visa Bulletin – Most Categories Hop Forward a Month or Two |
Hunton Andrews Kurth |
Mar 12 2024 |
China’s Supreme People’s Court Releases Summary of IP Judgements for 2023 |
Schwegman, Lundberg & Woessner, P.A. |
Mar 11 2024 |
China International Patent Filings Down 0.6% in 2023 But Maintains Lead as Top Filer |
Schwegman, Lundberg & Woessner, P.A. |
Mar 11 2024 |
Competition Currents | March 2024 |
Greenberg Traurig, LLP |
Mar 11 2024 |
Private Market Talks: Navigating the Geopolitical Supercycle with Tina Fordham [Podcast] |
Proskauer Rose LLP |
Mar 8 2024 |
China’s Supreme People’s Court Releases Work Report to the National People’s Congress |
Schwegman, Lundberg & Woessner, P.A. |
Mar 7 2024 |
China on the Move: Lessons from China’s 2023 National Negotiation of Drug Prices |
Greenberg Traurig, LLP |